Justifying the number of animals for each experiment

This publication has 10 references indexed in Scilit:

• Distribution of the 5-HT1A receptor antagonist [18F]FPWAY in blood and brain of the rat with and without isoflurane anesthesia
  European Journal of Nuclear Medicine and Molecular Imaging, 2006
• Exploring the sounds of silence: RNAi-mediated gene silencing for target identification and validation
  Drug Discovery Today, 2005
• [11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice
  Bioorganic & Medicinal Chemistry, 2005
• Sensitivity of [11C]N-methylpyrrolidinyl benzilate ([11C]NMPYB) to endogenous acetylcholine: PET imaging vs tissue sampling methods
  Nuclear Medicine and Biology, 2004
• Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industry
  Current Opinion in Pharmacology, 2003
• Inhibition of [18F]FP-TZTP binding by loading doses of muscarinic agonists P-TZTP or FP-TZTP in vivo is not due to agonist-induced reduction in cerebral blood flow
  Synapse, 2003
• The use of PET and knockout mice in the drug discovery process.
  Drug Discovery Today, 2003
• Knockouts model the 100 best-selling drugs—will they model the next 100?
  Nature Reviews Drug Discovery, 2003
• Sensitivity of New Radiopharmaceuticals
  Nuclear Medicine and Biology, 1998
• Identifiability Analysis of an In Vivo Receptor-Binding Radiopharmacokinetic System
  IEEE Transactions on Biomedical Engineering, 1985